David Grayzel is a partner at Atlas Venture focusing on novel therapeutics near first-in-human testing. He has co-founded and led numerous biotech companies, serving on multiple boards.
What David can write
Career
- Arteaus Therapeutics · Chief Executive Officeruntil 2014
- Annovation Biopharma · Chief Executive Officeruntil 2015
- Delinia · Founding Board Memberuntil 2017
- Cadent Therapeutics · Founding Board Memberuntil 2021
- Atlas Venture · PartnerNow
Companies founded
Investments named in public bios
Focus
Education
Also at Atlas Venture
Partners like David
At firms with a similar stage, sector and check size.
Alert me when Atlas Venture is active
One email when David's firm raises a fund, adds a partner or shows new activity.
Send Mode VC your deck
Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckQuestions
Who is David Grayzel?
David Grayzel is a partner at Atlas Venture focusing on novel therapeutics near first-in-human testing. He has co-founded and led numerous biotech companies, serving on multiple boards.
How much does David Grayzel invest?
Atlas Venture has not reported a check size. It invests at seed, series a.
How do I pitch David Grayzel?
A warm intro from a founder Atlas Venture backed works best. A short LinkedIn note with one line on traction is the next best route.
What did David Grayzel do before Atlas Venture?
Chief Executive Officer at Arteaus Therapeutics; Chief Executive Officer at Annovation Biopharma; Founding Board Member at Delinia; Founding Board Member at Cadent Therapeutics.
Last updated 2026-10-15. Is this you? Ask for a correction.